Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine, magnesium sulfate, meperidine, and tramadol for prevention of shivering during femoral fracture repair under spinal anesthesia
IRCT20141209020258N153Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine, magnesium sulfate, pethidine, tramadol and bupivacaine in postanesthetic shivering (PAS) (4 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Shivering intensity and Sedation. Started Mar 2021; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfatepethidinetramadolbupivacaine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20141209020258N153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N153.